Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mycosis Fungoides 3 Lymphoma, T-Cell, Cutaneous 3 Sezary Syndrome 2 Melanoma 2 Sarcoma, Ewing 1 Sarcoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia 1 Hepatitis 1 Hematologic Neoplasms 1 Colitis 1 Carcinoma, Non-Small-Cell Lung 1 Anemia, Refractory, with Excess of Blasts 1 Anemia, Refractory 1

Interventions

Temozolomide 10 Cyclophosphamide 10 Vincristine 9 Etoposide 6 Doxorubicin 6 Irinotecan 5 palbociclib 4 cabozantinib 4 Topotecan 4 Melphalan 4 Magnetic Resonance Spectroscopy 4 X-Rays 3 Sirolimus 3 Phantoms, Imaging 3 Ifosfamide 3 Gemcitabine 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 olaparib 2 ivosidenib 2 irinotecan sucrosofate 2 ganitumab 2 cixutumumab 2 Vemurafenib 2 Trabectedin 2 Tacrolimus 2 Specimen Handling 2 Peripheral Blood Stem Cell Transplantation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sarcoma, Ewing × Methoxsalen × Clear all

NCT03778996 2025-02-24

HopES

Sarcoma Oncology Research Center, LLC

Phase 2 Active not recruiting

Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡